Paul Klenerman

85.1k total citations · 5 hit papers
500 papers, 27.7k citations indexed

About

Paul Klenerman is a scholar working on Immunology, Epidemiology and Hepatology. According to data from OpenAlex, Paul Klenerman has authored 500 papers receiving a total of 27.7k indexed citations (citations by other indexed papers that have themselves been cited), including 264 papers in Immunology, 194 papers in Epidemiology and 154 papers in Hepatology. Recurrent topics in Paul Klenerman's work include Immune Cell Function and Interaction (202 papers), Hepatitis C virus research (142 papers) and T-cell and B-cell Immunology (137 papers). Paul Klenerman is often cited by papers focused on Immune Cell Function and Interaction (202 papers), Hepatitis C virus research (142 papers) and T-cell and B-cell Immunology (137 papers). Paul Klenerman collaborates with scholars based in United Kingdom, United States and Germany. Paul Klenerman's co-authors include Rolf M. Zinkernagel, Eleanor Barnes, Bruce D. Walker, Michaela Lucas, Christian B. Willberg, Rodney E. Phillips, Annette Oxenius, Rodney Phillips, Philip Goulder and Georg M. Lauer and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Paul Klenerman

491 papers receiving 27.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus

2000 1.1k citations Raymond T. Chung, Gregory K. Robbins et al. profile →
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1997 538 citations Paul Klenerman et al. profile →
Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells

2014 384 citations Luzheng Xue, Paul Klenerman et al. profile →
Hepatitis C

2015 323 citations Paul Klenerman et al. profile →
N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting

2023 116 citations Susanna Dunachie, Paul Klenerman et al. profile →

Peers

Countries citing papers authored by Paul Klenerman

Since Specialization

Citations

This map shows the geographic impact of Paul Klenerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Klenerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Klenerman more than expected).

Fields of papers citing papers by Paul Klenerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Klenerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Klenerman. The network helps show where Paul Klenerman may publish in the future.

Co-authorship network of co-authors of Paul Klenerman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Klenerman. A scholar is included among the top collaborators of Paul Klenerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Klenerman. Paul Klenerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines 2025 ·Science Immunology ·Sam M. Murray, Ali Amini, Helen Ferry, Lucy C. Garner, (unknown), Barbara Kronsteiner, Sagida Bibi, Andrew J. Pollard, Eleanor Barnes, Teresa Lambe, Susanna Dunachie, Paul Klenerman, Nicholas M. Provine	0
2	Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity 2024 ·Current Opinion in Virology ·Ali Amini, Paul Klenerman, Nicholas M. Provine	0
3	Fine needle aspiration of human lymph nodes reveals cell populations and soluble interactors pivotal to immunological priming 2024 ·European Journal of Immunology ·Nicholas M. Provine, Adam Al‐Diwani, Devika Agarwal, (unknown), (unknown), Andrew G. Murchison, Lucy C. Garner, Fintan Sheerin, Paul Klenerman, Sarosh R. Irani	5
4	IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma 2024 ·Mucosal Immunology ·Jian Luo, Wentao Chen, Wei Liu, Shan Jiang, (unknown), Rahul Shrimanker, Gareth Hynes, Paul Klenerman, Ian Pavord, Luzheng Xue	12
5	A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and mice 2022 ·Nature Communications ·Carl-Philipp Hackstein, (unknown), (unknown), Claire Pearson, Samuel J. Bullers, Nicholas E. Ilott, Hossain Delowar Akther, (unknown), Michael Fitzpatrick, Oliver J. Harrison, Lucy C. Garner, Elizabeth H. Mann, Sumeet Pandey, Matthias Friedrich, Nicholas M. Provine, Holm H. Uhlig, Emanuele Marchi, Fiona Powrie, Paul Klenerman, Emily Thornton	11
6	Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies 2022 ·Microbiology Spectrum ·Maisha Jabeen, Nicholas D. Sanderson, Dona Foster, Derrick W. Crook, Jennifer Cane, Catherine Borg, Clare Connolly, Samantha Thulborn, Ian Pavord, Paul Klenerman, (unknown), Timothy Hinks	12
7	Review 1: "Outcome of SARS-CoV-2 infection linked to MAIT cell activation and cytotoxicity: evidence for an IL-18 dependent mechanism" 2020 ·Paul Klenerman, Ali Amini	1
8	Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma 2020 ·Nature Medicine ·Benjamin P. Fairfax, Chelsea Taylor, Robert Watson, Isar Nassiri, Sara Danielli, Hai Fang, Elise A. Mahé, Rosalin Cooper, Victoria K. Woodcock, Zoë Traill, Hussein Al‐Mossawi, Julian C. Knight, Paul Klenerman, Miranda Payne, Mark R. Middleton	198
9	First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults 2019 ·Clinical Infectious Diseases ·Paola Cicconi, Claire Jones, (unknown), Laura Silva-Reyes, Paul Klenerman, Catherine de Lara, Claire Hutchings, Philippe Moris, Michel Janssens, Laurence Fissette, (unknown), Amanda Leach, (unknown), Ilse Dieussaert, Matthew D. Snape	43
10	The (gradual) rise of memory inflation 2018 ·Immunological Reviews ·Paul Klenerman	60
11	Human MAIT cells show metabolic quiescence with rapid glucose‐dependent upregulation of granzyme B upon stimulation 2018 ·Immunology and Cell Biology ·Madeleine E. Zinser, Andrew J. Highton, Ayako Kurioka, Barbara Kronsteiner, Joachim Hagel, Tianqi Leng, Emanuele Marchi, Chansavath Phetsouphanh, Christian B. Willberg, Susanna Dunachie, Paul Klenerman	32
12	Diverse Streptococcus pneumoniae Strains Drive a Mucosal-Associated Invariant T-Cell Response Through Major Histocompatibility Complex class I–Related Molecule–Dependent and Cytokine-Driven Pathways 2017 ·The Journal of Infectious Diseases ·Ayako Kurioka, Bonnie van Wilgenburg, (unknown), (unknown), Andries J. van Tonder, (unknown), Tianqi Leng, Lauren J. Howson, Dawn Shepherd, Vincenzo Cerundolo, Angela B. Brueggemann, Paul Klenerman	43
13	Adenoviral vaccine induction of CD8+ T cell memory inflation: Impact of co-infection and infection order 2017 ·PLoS Pathogens ·Lian Ni Lee, Beatrice Bolinger, Zoltán Bánki, Catherine de Lara, Andrew J. Highton, Julia Colston, Claire Hutchings, Paul Klenerman	10
14	Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection 2016 ·PLoS Pathogens ·Jayna Raghwani, Rebecca Rose, Isabelle Sheridan, Philippe Lemey, Marc A. Suchard, Teresa Santantonio, Patrizia Farci, Paul Klenerman, Oliver G. Pybus	29
15	POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer 2015 ·Clinical Cancer Research ·Inge C. van Gool, Florine A. Eggink, Luke Freeman-Mills, Ellen Stelloo, Emanuele Marchi, Marco de Bruyn, Claire Palles, Remi A. Nout, Cor D. de Kroon, Elisabeth M. Osse, Paul Klenerman, Carien L. Creutzberg, Ian Tomlinson, Vincent T.H.B.M. Smit, Hans W. Nijman, Tjalling Bosse, David N. Church	231
16	Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8 ⁺ T Cells during Persistent Hepatitis C Virus Infection 2005 ·Journal of Virology ·Simon Rushbrook, Scott M. Ward, Esther Unitt, Sarah L. Vowler, Michaela Lucas, Paul Klenerman, Graeme Alexander	233
17	Full-Breadth Analysis of CD8 ⁺ T-Cell Responses in Acute Hepatitis C Virus Infection and Early Therapy 2005 ·Journal of Virology ·Georg M. Lauer, Michaela Lucas, Jörg Timm, Kei Ouchi, Arthur Y. Kim, Cheryl L. Day, Julian Schulze zur Wiesch, Gláucia Paranhos‐Baccalà, Isabelle Sheridan, Deborah Casson, Markus Reiser, Rajesh T. Gandhi, Bin Li, Todd M. Allen, Raymond T. Chung, Paul Klenerman, Bruce D. Walker	85
18	Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers 2003 ·Journal of Clinical Investigation ·Cheryl L. Day, Nilufer P. Seth, Michaela Lucas, Heiner Appel, Laurent Gauthier, Georg M. Lauer, Gregory K. Robbins, Zbigniew M. Szczepiorkowski, Deborah Casson, Raymond T. Chung, (unknown), Gillian Harcourt, Bruce D. Walker, Paul Klenerman, Kai W. Wucherpfennig	222
19	Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells 2002 ·European Journal of Immunology ·Lukas Hunziker, Paul Klenerman, Rolf M. Zinkernagel, Stephan Ehl	40
20	Ritter's disease and sclerema; report on two rare cases in infants. 1952 ·PubMed ·Paul Klenerman	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact